ciprofloxacin + piperacillin + tazobactam

This is a combination of three antibiotics—ciprofloxacin, piperacillin, and tazobactam—used together for the treatment of severe or complicated bacterial infections. Ciprofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication. Piperacillin is an extended-spectrum penicillin (ureidopenicillin) that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Tazobactam is a beta-lactamase inhibitor that protects piperacillin from enzymatic degradation by beta-lactamases produced by certain bacteria, thus extending its spectrum of activity. This combination may be used in clinical settings where broad-spectrum coverage against Gram-negative (including *Pseudomonas aeruginosa*), Gram-positive, and anaerobic bacteria is required—for example in severe intra-abdominal infections or hospital-acquired pneumonia[3][9]. The use of this triple regimen should be guided by local susceptibility patterns and reserved for situations where monotherapy or dual therapy may not provide adequate coverage.

Other names

ciprofloxacin and piperacillin/tazobactamcipro + pip/tazo